US Patent 11780918 Markers of acute myeloid leukemia stem cells
Article
Patent abstract
Markers of acute myeloid leukemia stem cells (AMLSC) are identified. The markers are differentially expressed in comparison with normal counterpart cells, and are useful as diagnostic and therapeutic targets.